Vaneck Biotech Etf Price Prediction

BBH Etf  USD 166.58  0.43  0.26%   
As of 28th of March 2024, the relative strength momentum indicator of VanEck Biotech's share price is approaching 45 suggesting that the etf is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling VanEck Biotech, making its price go up or down.

Oversold Vs Overbought

45

 
Oversold
 
Overbought
VanEck Biotech ETF etf price prediction is an act of determining the future value of VanEck Biotech shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of VanEck Biotech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of VanEck Biotech and does not consider all of the tangible or intangible factors available from VanEck Biotech's fundamental data. We analyze noise-free headlines and recent hype associated with VanEck Biotech ETF, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether etf price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of VanEck Biotech based on different types of headlines from major news networks to social media. The VanEck price prediction module provides an analysis of price elasticity to changes in media outlook on VanEck Biotech over a specific investment horizon. Using VanEck Biotech hype-based prediction, you can estimate the value of VanEck Biotech ETF from the perspective of VanEck Biotech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards VanEck Biotech using VanEck Biotech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards VanEck using crowd psychology based on the activity and movement of VanEck Biotech's stock price.

VanEck Biotech Implied Volatility

    
  0.0  
VanEck Biotech's implied volatility exposes the market's sentiment of VanEck Biotech ETF stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if VanEck Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that VanEck Biotech stock will not fluctuate a lot when VanEck Biotech's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in VanEck Biotech. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in VanEck Biotech to buy its etf at a price that has no basis in reality. In that case, they are not buying VanEck because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

VanEck Biotech after-hype prediction price

    
  USD 167.05  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current VanEck contract

Based on the Rule 16, the options market is currently suggesting that VanEck Biotech ETF will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-04-19 option contract. With VanEck Biotech trading at USD 166.58, that is roughly USD 0.0 . If you think that the market is fully incorporating VanEck Biotech's daily price movement you should consider acquiring VanEck Biotech ETF options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out VanEck Biotech Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VanEck Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
152.26153.22183.71
Details
Naive
Forecast
LowNextHigh
165.73166.69167.65
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
164.06165.79167.52
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as VanEck Biotech. Your research has to be compared to or analyzed against VanEck Biotech's peers to derive any actionable benefits. When done correctly, VanEck Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in VanEck Biotech ETF.

VanEck Biotech After-Hype Price Prediction Density Analysis

As far as predicting the price of VanEck Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in VanEck Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of VanEck Biotech, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

VanEck Biotech Estimiated After-Hype Price Volatility

In the context of predicting VanEck Biotech's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on VanEck Biotech's historical news coverage. VanEck Biotech's after-hype downside and upside margins for the prediction period are 166.09 and 168.01, respectively. We have considered VanEck Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
166.58
166.09
Downside
167.05
After-hype Price
168.01
Upside
VanEck Biotech is very steady at this time. Analysis and calculation of next after-hype price of VanEck Biotech ETF is based on 3 months time horizon.

VanEck Biotech Etf Price Prediction Analysis

Have you ever been surprised when a price of a ETF such as VanEck Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VanEck Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with VanEck Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.02 
0.96
 0.00  
 0.00  
2 Events / Month
3 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
166.58
167.05
0.02 
533.33  
Notes

VanEck Biotech Hype Timeline

On the 28th of March VanEck Biotech ETF is traded for 166.58. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. VanEck is forecasted to increase in value after the next headline, with the price projected to jump to 167.05 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.02%, whereas the daily expected return is currently at 0.02%. The volatility of related hype on VanEck Biotech is about 612.77%, with the expected price after the next announcement by competition of 166.58. Considering the 90-day investment horizon the next forecasted press release will be in a few days.
Check out VanEck Biotech Basic Forecasting Models to cross-verify your projections.

VanEck Biotech Related Hype Analysis

Having access to credible news sources related to VanEck Biotech's direct competition is more important than ever and may enhance your ability to predict VanEck Biotech's future price movements. Getting to know how VanEck Biotech rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how VanEck Biotech may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MDEVFirst Trust Exchange Traded 0.01 2 per month 0.69 (0.04) 1.47 (1.43) 4.18 
MEDXHorizon Kinetics Medical 0.30 2 per month 0.82 (0.01) 1.56 (1.45) 4.12 
MEDIHarbor Health Care 0.18 2 per month 0.57  0.04  1.71 (1.13) 4.69 
MGNRAMERICAN BEACON GLG 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MISLFirst Trust Indxx 0.22 3 per month 0.42 (0.02) 1.06 (0.90) 3.02 
VGSRVert Global Sustainable(0.16)2 per month 0.85 (0.14) 1.26 (1.46) 4.01 
DTREFirst Trust Exchange Traded 0.80 4 per month 0.00 (0.18) 1.44 (1.67) 3.83 
DUSLDirexion Daily Industrials 0.04 1 per month 1.61  0.17  3.98 (3.16) 8.37 
MORTVanEck Mortgage REIT 0.02 2 per month 0.00 (0.13) 2.38 (2.53) 6.48 

VanEck Biotech Additional Predictive Modules

Most predictive techniques to examine VanEck price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VanEck using various technical indicators. When you analyze VanEck charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About VanEck Biotech Predictive Indicators

The successful prediction of VanEck Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as VanEck Biotech ETF, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of VanEck Biotech based on analysis of VanEck Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to VanEck Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to VanEck Biotech's related companies.

Story Coverage note for VanEck Biotech

The number of cover stories for VanEck Biotech depends on current market conditions and VanEck Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that VanEck Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about VanEck Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out VanEck Biotech Basic Forecasting Models to cross-verify your projections.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for VanEck Etf analysis

When running VanEck Biotech's price analysis, check to measure VanEck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VanEck Biotech is operating at the current time. Most of VanEck Biotech's value examination focuses on studying past and present price action to predict the probability of VanEck Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VanEck Biotech's price. Additionally, you may evaluate how the addition of VanEck Biotech to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.